Andreas Halvorsen - Viking Global Investors
Holding/activity history for Gracell Biotechnologies Inc (GRCL)
| Period | Shares | % of Portfolio | Activity | % Change to Portfolio | Reported Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| 2022 Q1 | 0 | 0.00 | Sell 100.00% | 0.01 | SEC | ||
| 2021 Q4 | 491,647 | 0.01 | Reduce 63.79% | 0.03 | $6.04 | $2,970,000 | SEC |
| 2021 Q3 | 1,357,859 | 0.05 | Add 2.07% | <0.01 | $13.87 | $18,834,000 | SEC |
| 2021 Q2 | 1,330,328 | 0.05 | Reduce 1.10% | <0.01 | $13.00 | $17,294,000 | SEC |
| 2021 Q1 | 1,345,076 | 0.06 | Buy | 0.06 | $15.40 | $20,714,000 | SEC |